10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
robin carhart harris
3 stories
10/9/2026
Peaking documentary explores psychedelic healing
Film offers rare insight into psychedelic therapy for trauma and addiction.
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.